Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases (2026) Düsing C, Györfi AH, Stütz AN, Lahu LM, Deicher FS, Li YN, Bruch PM, et al. Journal article Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases (2026) Becilli M, Metzler M, Bracaglia C, Nicolai R, Krickau T, Del Bufalo F, Rosignoli C, et al. Journal article Resetting autoimmune disease with CAR cell therapies (2026) Schett G, Xu H Journal article, Review article Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals (2026) Neuen BL, Major RW, Grams ME, Sang Y, Coresh J, Ballew SH, Surapaneni A, et al. Journal article Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling (2026) Suissa D, Fidelle M, Reich E, Pham TN, Thomas S, Björk JR, Liu P, et al. Journal article Polygenic prediction of body mass index and obesity through the life course and across ancestries (2025) Smit RA, Wade KH, Hui Q, Arias JD, Yin X, Christiansen MR, Yengo L, et al. Journal article BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells (2025) Müller F, Wirsching A, Hagen M, Völkl S, Tur C, Raimondo MG, Taubmann J, et al. Journal article Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial (2025) McInnes IB, Coates LC, Mease PJ, Ogdie A, Kavanaugh A, Eder L, Schett G, et al. Journal article Impact of the ONCOBIOME network in cancer microbiome research (2025) Zitvogel L, Derosa L, Routy B, Loibl S, Heinzerling L, Heinzerling L, de Vries IJM, et al. Journal article, Review article Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2− breast cancer: a randomized phase 3 trial (2025) Cardoso F, O’Shaughnessy J, Liu Z, McArthur H, Schmid P, Cortes J, Harbeck N, et al. Journal article